We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

132 hedge funds and large institutions have $436M invested in 2seventy bio in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 20 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 20

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

1% less funds holding

Funds holding: 133132 (-1)

20% less capital invested

Capital invested by funds: $544M → $436M (-$108M)

31% less call options, than puts

Call options by funds: $398K | Put options by funds: $578K

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
25
Increased
44
Reduced
20
Closed
22
Calls
$398K
Puts
$578K
Net Calls
-$180K
Net Calls Change
-$575K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$3.55M +$1.34M +98,686 +58%
RCMNY
27
Rubric Capital Management (New York)
New York
$3.5M +$3.61M +265,000 New
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$3.15M -$987K -72,400 -23%
Morgan Stanley
29
Morgan Stanley
New York
$2.78M -$2.56M -187,683 -47%
6CM
30
683 Capital Management
New York
$2.77M -$3.84M -281,803 -57%
Mirae Asset Global Investments
31
Mirae Asset Global Investments
South Korea
$2.19M +$1.3M +95,062 +134%
WAM
32
Weiss Asset Management
Massachusetts
$2.14M +$2.21M +161,943 New
CH
33
CVI Holdings
Delaware
$1.7M -$9.41M -690,833 -84%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.68M +$546K +40,084 +46%
N
35
Nuveen
North Carolina
$1.48M +$368K +27,003 +32%
Citadel Advisors
36
Citadel Advisors
Florida
$1.33M +$1.37M +100,490 New
Citigroup
37
Citigroup
New York
$1.19M +$716K +52,543 +140%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$1.17M +$198K +14,508 +19%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.15M -$1.81M -133,030 -60%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.11M
ACM
41
Altium Capital Management
New York
$1.1M -$436K -32,000 -28%
MIM
42
Monashee Investment Management
Massachusetts
$1.06M +$1.09M +80,000 New
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$1.03M +$1.06M +77,759 New
Deutsche Bank
44
Deutsche Bank
Germany
$917K +$754K +55,366 +392%
Bank of America
45
Bank of America
North Carolina
$833K -$3.68M -269,777 -81%
BC
46
Birchview Capital
Vermont
$790K +$347K +25,500 +74%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$717K +$330K +24,197 +80%
CCM
48
Camber Capital Management
Massachusetts
$642K +$662K +48,600 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$609K +$81.1K +5,950 +15%
UBS AM
50
UBS AM
Illinois
$602K +$485K +35,558 +354%

TSVT Hedge Fund Activity: Q2 2022 in Review

132 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2022, worth a combined $436M — down 20% from $544M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TSVT positions and 22 closed out — a net gain of 3 holders — while 44 added to existing stakes and 20 trimmed.

The largest buyer was Vanguard Group, adding an estimated $12.9M. The largest seller was CVI Holdings, cutting an estimated $9.41M.

  • 132 institutional investors held 2seventy bio (TSVT) as of Q2 2022, down from 133 in Q1 2022.
  • Funds reported $436M of 2seventy bio stock for Q2 2022, down 20% quarter-over-quarter.
  • 25 funds opened new 2seventy bio positions in Q2 2022 and 22 closed out, a net change of +3 holders.
  • The largest 2seventy bio buyer in Q2 2022 was Vanguard Group, an estimated $12.9M added.
  • The largest 2seventy bio seller in Q2 2022 was CVI Holdings, an estimated $9.41M sold.

Based on aggregated 13F filings for Q2 2022.